# Filing Detail

Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]
SEC Accession No. 0001193125-17-211880
Filing Date
2017-06-23
Accepted
2017-06-23 17:01:00
Documents
5

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-A12B/A | d406180d8a12ba.htm | 8-A12B/A | 16352
2 | EX-3.4 | d406180dex34.htm | EX-3.4 | 107388
3 | EX-4.1 | d406180dex41.htm | EX-4.1 | 3891
4 | GRAPHIC | g406180page017.jpg | GRAPHIC | 481086
5 | GRAPHIC | g406180page018.jpg | GRAPHIC | 190091
| Complete submission text file | 0001193125-17-211880.txt |  | 1053479

Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B/A | Act: 34 | File No.: 001-36620 | Film No.: 17928284
SIC: 2834 Pharmaceutical Preparations